Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Follow-up care after treatment of bile duct/gallbladder cancer

Patients who have completed treatment intended to cure primary bile duct cancer should be followed-up every 3 months for the first year, thereafter every 6 months. The frequency and duration of follow-up is individual and based on the treatment modality. In patients having a non-curative treatment, the frequency should be according to the needs of the patient.   

Follow-up of the patient should take place at the treatment center. After one year, if geographical conditions require, the follow-up can be performed at the patient's local hospital. Tests performed at follow-up:

  • CT scan of liver (3 phase), possibly MRI
  • Ultrasound of the liver, possibly with contrast
  • MRCP, possibly ERCP
  • CT scan of thorax
  • Blood tests (liver tests and cancer markers, among others). Cancer markers (CEA, CA 19-9, AFP)  may provide postoperative prognostic information in patients who had raised levels before treatment.

Transplant patients are included in Oslo University Hospital's separate follow-up arrangement after the transplant.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018